XML 32 R25.htm IDEA: XBRL DOCUMENT v3.24.2
Development, Commercialization and Supply Agreements (Tables)
6 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Summary of Product Approval

The Company received approval of VASCEPA under the MARINE and REDUCE-IT indications in the following countries:

Country

 

MARINE

 

REDUCE-IT

 

Launch Date

Lebanon

 

March 2018

 

August 2021

 

June 2018

United Arab Emirates

 

July 2018

 

October 2021

 

February 2019

Qatar

 

December 2019

 

April 2021

 

N/A

Bahrain

 

April 2021

 

April 2022

 

N/A

Kuwait

 

December 2021

 

March 2023

 

September 2023

Saudi Arabia

 

March 2022

 

June 2023

 

September 2023

Changes in Balances of Contract Assets and Liabilities and Revenues Recognized

The following table presents changes in the balances of the Company’s contract assets and liabilities during the six months ended June 30, 2024 and 2023:

 

In thousands

Balance at Beginning of Period

 

 

Additions

 

 

Deductions

 

 

Balance at
End of Period

 

Six months ended June 30, 2024:

 

 

 

 

 

 

 

 

 

 

 

Contract assets

$

 

 

$

 

 

$

 

 

$

 

Contract liabilities:

 

 

 

 

 

 

 

 

 

 

 

Deferred revenue (1)

$

4,850

 

 

$

 

 

$

(4,850

)

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

Six months ended June 30, 2023:

 

 

 

 

 

 

 

 

 

 

 

Contract assets

$

 

 

$

 

 

$

 

 

$

 

Contract liabilities:

 

 

 

 

 

 

 

 

 

 

 

Deferred revenue (2)

$

15,346

 

 

$

5,000

 

 

$

(14,990

)

 

$

5,356

 

 

(1) The approximately $4.9 million reduction consists primarily of recognition of $4.0 million relating to the change in estimate for Edding during the three months ended June 30, 2024.

 

(2) The approximately $15.0 million reduction consists of recognition of $5.0 million and $5.3 million relating to the change in estimate for Edding and HLS, respectively, as well as recognizing, based on the revised timeline $3.9 million for the MARINE indication approval in China achieved during the three months ended June 30, 2023.

During the six months ended June 30, 2024 and 2023, the Company recognized the following revenues as a result of changes in the contract asset and contract liability balances in the respective periods:

 

In thousands

Six months ended June 30,

 

Revenue recognized in the period from:

2024

 

 

2023

 

Amounts included in contract liability at the beginning of the period

$

1,180

 

 

$

11,097

 

Performance obligations satisfied in previous periods

$

3,670

 

 

$

1,722